The U.S. Supreme Court. Getty Images photo.
The U.S. Supreme Court issued an important 5-4 decision in T.M. v. University of Maryland Medical System, affirming a basic but critical principle of our judicial system: Litigants should not be permitted to simultaneously challenge the same state-court judgment in federal district court while state appellate proceedings remain ongoing.
The court held that the longstanding Rooker Feldman doctrine bars such duplicative federal litigation, even when a state-court judgment is still subject to appeal.
While the legal issue before the Court was procedural, the implications for patients, physicians, hospitals, and the integrity of our judicial system are substantial.
The Maryland State Medical Society (MedChi) joined the American Medical Association in filing an amicus brief because healthcare professionals and institutions depend on clear, predictable legal processes.
Physicians make difficult decisions every day, often in emergency and behavioral health settings where patient safety, public safety, and individual rights must all be carefully balanced. Those decisions are already subject to extensive review through administrative proceedings, state courts, professional licensing oversight and established appellate processes.
Allowing parties dissatisfied with a state-court ruling to immediately seek a second review in federal district court before the state process is complete would create confusion, encourage forum shopping and dramatically increase litigation costs. It could also produce conflicting judicial decisions arising from the same underlying facts. The result would be uncertainty for patients and healthcare professionals alike.
The Supreme Court recognized this concern. Writing for the majority, Justice Sonia Sotomayor concluded that federal district courts cannot serve as alternative appellate tribunals for state-court judgments simply because state appeals remain pending.
The decision preserves the proper relationship between state and federal courts and reinforces the principle that litigants must follow established appellate pathways.
Importantly, this ruling does not deprive individuals of access to justice. Parties remain free to pursue their claims through state appellate courts and, when appropriate, seek review by the United States Supreme Court itself. What the court rejected was an attempt to create parallel tracks of litigation that could undermine judicial consistency and finality.
For Maryland physicians, this case arose from a particularly sensitive context involving involuntary psychiatric treatment and related judicial proceedings. These situations are among the most challenging encountered in medicine. Clinicians must often act quickly while balancing patient autonomy, safety concerns, medical evidence and legal requirements. When disputes arise, healthcare professionals deserve a judicial system that is orderly, predictable, and capable of reaching final resolutions.
While MedChi is a close ally with UMMS, MedChi and the AMA did not participate in this case to advocate for any particular healthcare institution. We participated because the broader principle matters. Healthcare delivery depends on stable legal frameworks. Courts function best when each level of the judicial system respects the role of the others. By reaffirming those boundaries, the Supreme Court protected not only federalism and judicial efficiency, but also the ability of physicians and healthcare systems to operate within a coherent legal environment.
The Court’s decision may not generate the headlines of more politically charged cases, but it reinforces a foundational principle of American jurisprudence: There must be one orderly path for appellate review. In T.M. v. UMMS, the Supreme Court got it right.
Courtesy of Maryland Matters
